Stay updated with the latest active-ingredient news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on active-ingredient topics.
HYDERABAD, India -- The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India's southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday. The fire department recovered the charred bodies of 34 workers from the accident site in an industrial area about 50 kilometers (31 miles) from the state capital Hyderabad, the state's fire services director G.V. Narayana Rao told The Associated Press. Two othe ...Read More >
Sangareddy (Telangana), Jun 30 (PTI) At least 12 people died and 34 persons were injured in a pharma plant explosion in this district on Monday, Telangana Minister Damodara Raja Narasimha said. "As many as 12 people died and 34 people are under treatment. We are hopeful that there would be no more (deaths)," the health minister told reporters. Labour Minister G Vivek Venkatswamy said: "Eight people died in the morning. Now, four bodies were found." Both the ministers visited the site. The exp ...Read More >
Sangareddy (Telangana), Jun 30 (PTI) Eight people were killed and 26 others injured in an explosion triggered by a suspected chemical reaction in a pharma plant in this district on Monday, officials said. The explosion took place at a reactor in the plant of Sigachi pharma company in the Pashamylaram industrial estate due to the suspected chemical reaction where fire also broke out. Prime Minister Narendra Modi condoled the deaths. Inspector General of Police (Multizone) V Satyanarayana said: ...Read More >
Sangareddy (Telangana), Jun 30 (PTI) As many as eight were killed and several others suffered injuries in a suspected explosion in a pharma plant in this district on Monday, officials said. Several workers are feared trapped at the accident site in the Sigachi pharma company at the Pashamylaram industrial estate and efforts were on to rescue them, they said. "We have recovered six bodies from the accident site, and two died in the hospital," a fire department official told PTI. The injured pe ...Read More >
Hyderabad: Chief Minister A Revanth Reddy on Monday expressed anguish over the explosion at Sigachi Pharma Company in the Pashamylaram industrial estate and directed officials to take all steps to save the trapped workers and provide them advanced medical care. Several workers are feared trapped at the accident site in the pharma company and efforts were on to rescue them, official sources said. The injured people were shifted to hospitals and their condition was not known immediately, as the ...Read More >
Sangareddy (Telangana), Jun 30 (PTI) At least two persons were killed and about 14 others suffered injuries in a suspected explosion in a pharma plant in this district on Monday, police said. Several workers are feared trapped at the accident site in the Sigachi pharma company at the Pashamylaram industrial estate and efforts were on to rescue them, official sources said. The injured people were shifted to hospitals and their condition was not known immediately, as the rescue operation was sti ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to nex ...Read More >
A pharmaceutical stock has hit the 20 percent upper circuit limit following the announcement of its plans to enter the real estate business. This move has sparked investor interest as the company shifts focus to a new sector. During Monday's trading session, the share price of Par Drugs & Chemicals Ltd locked a 20 percent upper circuit of Rs.348.45 per share, from its previous close of Rs.290.40 apiece. Over the past six months, the stock has delivered over 60 percent returns. Par Drugs and Ch ...Read More >
AstraZeneca is benefiting from surging demand for cancer treatments like Imfinzi and Calquence, and has a robust pipeline expected to deliver two dozen new products by 2030. Leading vaccine makers like Eli Lilly (NYSE:LLY), Pfizer (NYSE:PFE), and AstraZeneca NASDAQ:AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic, but now there is reason to expect renewed interest. As investors look ahead to the second Trump administration, the incoming president's nomination of ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.